1. Collaborative care approaches for people with severe mental illness
- Author
-
Reilly, S., Hobson-Merrett, C., Gibbons, B., Jones, B., Richards, D., Plappert, H., Gibson, J., Green, M., Gask, L., Huxley, P.J., Druss, B.G., Planner, C.L., Reilly, S., Hobson-Merrett, C., Gibbons, B., Jones, B., Richards, D., Plappert, H., Gibson, J., Green, M., Gask, L., Huxley, P.J., Druss, B.G., and Planner, C.L.
- Abstract
Background Collaborative care for severe mental illness (SMI) is a community‐based intervention that promotes interdisciplinary working across primary and secondary care. Collaborative care interventions aim to improve the physical and/or mental health care of individuals with SMI. This is an update of a 2013 Cochrane review, based on new searches of the literature, which includes an additional seven studies. Objectives To assess the effectiveness of collaborative care approaches in comparison with standard care (or other non‐collaborative care interventions) for people with diagnoses of SMI who are living in the community. Search methods We searched the Cochrane Schizophrenia Study‐Based Register of Trials (10 February 2021). We searched the Cochrane Common Mental Disorders (CCMD) controlled trials register (all available years to 6 June 2016). Subsequent searches on Ovid MEDLINE, Embase and PsycINFO together with the Cochrane Central Register of Controlled Trials (with an overlap) were run on 17 December 2021. Selection criteria Randomised controlled trials (RCTs) where interventions described as 'collaborative care' were compared with 'standard care' for adults (18+ years) living in the community with a diagnosis of SMI. SMI was defined as schizophrenia, other types of schizophrenia‐like psychosis or bipolar affective disorder. The primary outcomes of interest were: quality of life, mental state and psychiatric admissions at 12 months follow‐up. Data collection and analysis Pairs of authors independently extracted data. We assessed the quality and certainty of the evidence using RoB 2 (for the primary outcomes) and GRADE. We compared treatment effects between collaborative care and standard care. We divided outcomes into short‐term (up to six months), medium‐term (seven to 12 months) and long‐term (over 12 months). For dichotomous data we calculated the risk ratio (RR) and for continuous data we calculated the standardised mean difference (SMD), with 95% confiden
- Published
- 2024